Clinical Trials Directory

Trials / Completed

CompletedNCT00840502

Ultrasound Study in Pregnant Women With Malaria

Impact of Malaria Infection in Pregnancy on Fetal and Newborn Growth

Status
Completed
Phase
Study type
Observational
Enrollment
1,887 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Most of the neonatal deaths that occur worldwide every year are associated with low birth weight (LBW), caused by intrauterine growth restriction (IUGR) and/or preterm delivery. Accurate assessment of fetal growth and gestational age for timely identification and management of growth restriction are therefore public health priorities, especially in developing countries where 98% of all neonatal deaths occur. Every year, more than 50 million women become pregnant in malaria endemic regions. Malaria infection at any time during pregnancy reduces birthweight. However, little is known about the relationship between the timing of infection during pregnancy and the extent of the impact on birth weight. The mechanisms by which malaria causes LBW also remain unclear. Reduced placental blood flow, placental changes, red blood cell changes, severe anaemia and pro-inflammatory cytokines have all been implicated. In this proposed, longitudinal, observational, minimal risk study, which will take place in SMRU antenatal clinics on the Thai-Burmese border, the effect of malaria infection during pregnancy on fetal growth will be determined. Women will be screened before 13+6 weeks of gestation and followed with regular ultrasound examinations during pregnancy. When a woman has a malaria infection an extra ultrasound scan will be done to measure growth retardation or placental blood flow changes. Bloodsamples will be taken to detect changes in red blood cell properties and putative markers of malaria infection. For this study the maximum amount of blood taken during pregnancy is 13 cc in an uninfected woman. For each malaria episode an additional 7 cc blood will be taken. After delivery a placenta and a cord sample will be taken to detect placental changes. The investigators aim to recruit four hundred pregnant women over the course of two years. This study involves minimal risk to participants as ultrasound examination is part of routine antenatal care in many countries in the world.

Conditions

Timeline

Start date
2009-02-10
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2009-02-10
Last updated
2020-09-02

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT00840502. Inclusion in this directory is not an endorsement.